FDA, DoD Sign MoU to Accelerate Availability of Medical Products for Military Servicemen

The Food and Drug Administration and the Defense Department have formalized the framework of an earlier plan to accelerate the development and availability of emergency medical products for the U.S. military.

FDA said Friday it signed a memorandum of understanding with the DoD's Office of Health Affairs to commence with the program's implementation, as provided for under House Resolution 4374 that was passed in 2017.

The MoU authorizes the FDA and the Pentagon to work toward faster deployment of medical products meant to diagnose, treat or prevent life-threatening conditions affecting U.S. service members, including those caused by chemical, biological, radiological or nuclear agents.

"It's our honor and duty to support our military personnel by ensuring they have access to safe and effective medical products – especially products that meet the unique needs and settings in which soldiers may require medical treatment," said FDA Commissioner Scott Gottlieb.

 

Check Also

FireEye

FireEye to Provide Cybersecurity Defenses to Texas DIR; Pat Sheridan Quoted

FireEye, Inc. has announced that it will offer cyber security defenses to Texas public sector agencies, under Texas Department of Information Resources (DIR), the company reported on Thursday. Through the end of 2020, FireEye security products and Mandiant Solutions services will be available to all Texas agencies, county governments, cities and school districts through DIR’s Bulk Purchase Initiative for Endpoint Detection and Response (EDR) solutions.